Former Assistant U.S. Surgeon General Roscoe M. Moore, Jr., DVM, PhD, MPH Joins the BioMedical Technology Solutions Scientifi...
December 20 2011 - 12:54PM
Marketwired
BioMedical Technology Solutions Holdings, Inc. ("BMTS," "the
Company") (OTCBB: BMTL) announced today the addition of former
Assistant U.S. Surgeon General Roscoe M. Moore, Jr., DVM, PhD, MPH
to its Scientific Advisory Board.
"We are honored and excited that Dr. Roscoe Moore will be
joining our esteemed Scientific Advisory Board. Dr. Moore's
experience and expertise with both national and international
public health issues make him an outstanding addition to our team.
Dr. Moore has an extensive background within the FDA and U.S.
Public Health Services that will allow him to lead our efforts in
the implementation of the Demolizer II where it is needed most. We
look forward to a long and productive relationship with Dr. Moore,"
stated Jonathan Bricken, CEO of BMTS.
The Demolizer II eliminates the need to store and frequently
handle biomedical waste by converting infectious biomedical waste
into noninfectious material. BMTS has initiated a campaign to place
Demolizer II machines in clinics, hospitals, care facilities and
other venues that regularly utilize medical syringes which could
harbor infectious diseases such as HIV and Hepatitis C.
BMTS recently began its outreach efforts to HIV clinicians and
care and service providers at the 2011 United States Conference on
AIDS (USCA) that took place this past November in Chicago,
Illinois. BMTS exhibited the Demolizer II alongside the National
Association of People with AIDS (NAPWA), demonstrating its
effectiveness in curbing the spread of HIV.
"I am pleased to join BioMedical Technology Solutions as a
member of their Scientific Advisory Board. The unsafe disposal of
contaminated syringes has long been a means of proliferation of HIV
through avoidable needlestick injuries due to improper disposal.
Eliminating this risk factor can be one of the less challenging HIV
prevention efforts by placing Demolizer II machines in clinics and
hospitals worldwide," said Dr. Moore.
About BioMedical Technology Solutions Holdings,
Inc. BioMedical Technology Solutions Holdings, Inc., located
in Englewood, Colorado, sells and rents the Demolizer® II through
its wholly owned subsidiary BioMedical Technology Solutions, Inc.
BMTS' patented Demolizer® Technology converts infectious biomedical
waste into non-infectious material. BMTS' products provide
biomedical waste treatment solutions for the over 1,000,000 low to
medium volume medical waste generators in the US and a global
market five times larger than the US. For more information, visit
http://www.bmtscorp.com/ or call 866-525-2687.
About the Demolizer® II The Demolizer® II
is the GREEN alternative to biomedical waste disposal. The device
is the only patented, portable, and self-contained system able to
process both sharps and typical red bag biomedical waste onsite.
The processed waste is rendered sterile and discarded as common
trash eliminating up to 100% of the cost associated with its
disposal. The Demolizer® II meets or exceeds all EPA and CDC
guidelines and is approved or meets treatment requirements in 48
states after review by 80 governmental agencies. The device uses no
chemicals or liquids, plugs into a normal outlet through a surge
protector, and automatically records and prints state required
documentation. The Demolizer® II provides a safer, more
environmentally GREEN method for biomedical waste disposal.
Safe Harbor for Forward Looking Statements
The statements contained in this press release may include certain
projections and forward looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended. Such
statements involve a number of risks and uncertainties. Such
statements reflect the Company's current views with respect to
future events and financial performance. No assurances can be given
however, that these events will occur or that such expectations
will be achieved and that actual results could differ materially
from those described. Actual results of future operations of
BioMedical Technology Solutions Holdings, Inc. may differ
materially from those indicated by these forward looking statements
as a result of various important factors.
Contact: Gex "Jay" F. Richardson BMTL President and Chairman
(954) 275-3309